13G Filing: Tappan Street Partners and Peregrine Pharmaceuticals Inc (PPHM)

 

 

CUSIP No .

713661502

Page 9 of 9

 

 

 

EXHIBIT
A

 

Joint
Filing Agreement

 

The
Undersigned agree that the statements on Schedule 13G with respect to the common stock of Peregrine Pharmaceuticals, Inc. dated
as of August ___, 2017, is, and any amendment thereto signed by each of the undersigned shall be, filed on behalf of each of them
pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.

 

 

Date:	August 14, 2017
Signature:	/s/ Prasad Phatak
Name:	Prasad Phatak
TAPPAN STREET PARTNERS FUND L.P. Date: August 14, 2017
By:	/s/ Prasad Phatak
Name:	Prasad Phatak
Title:	Managing Member of Tappan Street Partners LLC Investment Adviser to Tappan Street Partners Fund L.P.
TAPPAN STREET PARTNERS IDEAS FUND L.P. Date: August 14, 2017
By:	/s/ Prasad Phatak
Name:	Prasad Phatak
Title:	Managing Member of Tappan Street Partners LLC Investment Adviser to Tappan Street Partners Ideas Fund L.P.
TAPPAN STREET PARTNERS LLC Date: August 14, 2017
By:	/s/ Prasad Phatak
Name:	Prasad Phatak
Title:	Managing Member of Tappan Street Partners LLC